hero banner

Canadian Syncope Risk Score

CSRS · RISK STRATIFICATION

CSRS Assessment

Predicts 30-day serious adverse events in patients ≥16 yrs presenting ≤24h of syncope.

Do not use if: prolonged (>5 min) LOC, altered mental status, witnessed seizure, major trauma, intoxication, language barrier, or head trauma causing LOC. This tool supports clinical assessment only.

Predisposition to vasovagal symptoms

Triggered by being in a warm crowded place, prolonged standing, fear, emotion, or pain

±1

Heart disease history

CAD, atrial fibrillation or flutter, CHF, valvular disease

±1

sBP <90 or >180 mmHg

On any reading

±2

Elevated troponin

>99th percentile of normal population

±2

Abnormal QRS axis

<-30° or >100°

±1

QRS duration >130 ms

Prolonged QRS

±1

Corrected QT interval >480 ms

Prolonged QTc

±2

ED diagnosis

Based on ED evaluation

dx

Risk score

Select responses above — your risk score updates automatically.

Risk tiers

≤ -2Very low
-1 to 0Low
1–3Medium
≥ 4High

For reference only — verify against current protocol.

CPR Refresher

Compression : Ventilation

30:2

Regardless of officer numbers

Rate100–120 /min
Depth≥ 5 cm
Hand placement2 hands — lower sternum
CPR if pulse< 40 BPM
Advanced airway6–10 breaths/min (continuous compressions)

ALS Medications

Epinephrine1 mg IV/IO q3–5 min
Amiodarone300 mg IV/IO (refractory VF/VT)
Lidocaine1–1.5 mg/kg IV/IO (alt)
Magnesium1–2 g IV (torsades)
Sodium Bicarb1 mEq/kg IV (hyperK/TCA)
Peds GuideALS PCS v5.4
kg

Enter patient weight (0.5 – 149 kg)

Enter patient weight to calculate doses